Annemieke H. Van Der Hout

Groningen, GR 9713GZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Journal: American journal of human genetics

Published: March 29, 2024

BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study.

BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study.

Journal: Cancers

Published: March 29, 2024

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: February 29, 2024

Benefits, Recruitment, Dropout, and Acceptability of the Strength Back Digital Health Intervention for Patients Undergoing Spinal Surgery: Nonrandomized, Qualitative, and Quantitative Pilot Feasibility Study.

Benefits, Recruitment, Dropout, and Acceptability of the Strength Back Digital Health Intervention for Patients Undergoing Spinal Surgery: Nonrandomized, Qualitative, and Quantitative Pilot Feasibility Study.

Journal: JMIR formative research

Published: November 16, 2023

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.

Journal: The Journal of pathology

Published: May 26, 2023

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 03, 2023

Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Journal: Breast cancer research : BCR

Published: November 24, 2022

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: March 22, 2022

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Journal: Breast cancer research : BCR

Published: March 14, 2022

Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

Journal: European journal of human genetics : EJHG

Published: December 07, 2020

Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study.

Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study.

Journal: BMC pediatrics

Published: October 19, 2020

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease.

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease.

Journal: Frontiers in cell and developmental biology

Published: April 21, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026